News

The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...
Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...
There are standard solutions to the problem, but they are only partial solutions: In the past few months, I have written a ...
After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...
23andMe has said it wants to allow new bids by both parties with a deadline of 12th June, according to a Financial Times ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
“Rats are known to be the first thing off a burning ship. One leaves first, then the others get nervous. Tails curl up, noses wiggle, and eyes pop open wide. Moments later, it is a free-for-all, and ...
Coinbase recently disclosed a serious security breach in which unknown cybercriminals accessed highly sensitive user data.
Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based drugmaker is set to take over 23andMe after winning a bankruptcy ...
CBS News President and CEO Wendy McMahon announced her resignation on Monday because "the company and I do not agree on the path forward." Left unstated but hanging over her announcement ...
Regeneron is buying bankrupt genetic testing firm 23andMe, which helped usher in the era of consumer DNA test kits nearly two ...
(Reuters) -Drugmaker Regeneron Pharmaceuticals is acquiring majority assets of bankrupt genetic testing firm 23andMe Holding for $256 million. The once-sizzling DNA-testing startup filed for ...